secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001628280-24-039783
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics furnishes investor presentations; no material new disclosures
--------------------------------------------------------------------------------

- Filed Form 8-K on September 9, 2024 to disclose investor presentation and H.C. Wainwright conference slides.
- Presentations provided as Exhibit 99.1 and 99.2; no specific financial updates or guidance changes were included in the filing.
- Information is furnished under Regulation FD and not deemed filed for SEC liability purposes.
- No material new business developments, earnings data, or strategic actions were reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024039783/0001628280-24-039783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828024039783/aqst-20240909.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-039783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer